Elekta and Philips establish research consortium to leverage a breakthrough in cancer care with integration of a linear accelerator and MR Imaging

The combination of radiotherapy delivery and simultaneous magnetic resonance
imaging (MRI) is the next-generation innovation for treatment of cancer patients
using radiotherapy
Stockholm, SWEDEN and Amsterdam, THE NETHERLANDS October 25, 2012 – Elekta AB
(NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today
announced that they will  expand a joint program to develop a breakthrough in
cancer care with an imaging-treatment platform that merges radiation therapy and
magnetic resonance imaging (MRI) technology in a single treatment system. The
program for development will include a research consortium of leading radiation
oncology centers and clinicians, which today includes the University Medical
Center Utrecht (the Netherlands).

The establishment of the consortium marks the next step in the collaboration
between Elekta, a pioneer in neurosurgery and radiation therapy systems and
Philips, a leader in medical imaging systems. The consortium’s mission will be
to merge precision radiation delivery with MRI in a single MRI-guided radiation
therapy system*. This will enable doctors to achieve exceptional soft tissue
imaging during radiation therapy and to adapt treatment delivery in real-time
for extremely precise cancer treatments.

“Bringing the superior soft tissue imaging of MRI and precise radiotherapy
together in one device could potentially revolutionize cancer care,” says Tomas
Puusepp, President and CEO of Elekta AB. “The need to maximize therapeutic
radiation on the target, while minimizing the exposure of healthy tissue is
entirely driven by the best interests of the patient – they deserve the best
chance for a cure and an improved quality of life. Elekta and Philips are
leaders in the global healthcare community with a complete spectrum of expertise
to fulfill this vision.”

“Cancer is a major global disease that we hope to control with more targeted
treatments,” says Gene Saragnese, CEO Imaging Systems at Philips Healthcare.
“MRI is emerging in oncology applications because of its excellent real-time 3D
visualization of soft tissue. Together with our partners, all leaders in
radiation therapy delivery, we are convinced that the integrated MRI-guided
radiation therapy system has the potential to become a game changer in cancer
care on a global scale.”

Working with University Medical Center Utrecht, the medical device companies
have built and tested a prototype system that integrates a linear accelerator
and a 1.5 Tesla MRI system. The success of early tests has enabled the project
to move to the next phase of development and testing by a select group of
consortium partners.

“We are proud and excited about this project,” adds Prof. Jan Lagendijk,
Department of Radiotherapy, University Medical Center Utrecht. “Elekta, Philips
and my department have strived for over a decade to make this possible. Through
real-time imaging of both tumors and organs at risk, an integrated MR-guided
radiation therapy system would enable us to see more precisely than ever what we
treat, and irradiate just the tumor as it moves in the body during treatment.
This could potentially bring significant benefits to patients and overall
healthcare economics.”

Radiotherapy is one of the primary modalities used to treat cancer, either as a
stand- alone treatment or used with other modalities such as chemotherapy. The
technique involves identifying cancerous tissue and irradiating it with high
energy radiation beams in a way that maximizes sparing of healthy tissue near
the tumor. Radiation therapy delivered by linear accelerators and medical
imaging already play an essential role in treatment planning, delivery and after
care and is a proven cost-effective and safe method for treating patients with
cancer.

*The integrated MRI-guided radiation therapy system is in development and not
available for sale.

For further information, please contact:
Johan Andersson Melbi
Director, Investor Relations, Elekta AB
Tel: +46 702 100 451
E-mail: johan.anderssonmelbi@elekta.com
Time zone: CET: Central European Time

Michelle Joiner
Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
E-mail: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

Steve Klink
Philips Corporate Communications
Tel.: +31 20 5977415
E-mail: steve.klink@philips.com

The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 07:30 CET on October 25, 2012.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both healthcare providers and patients,
Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHI) is a diversified health and well
-being company, focused on improving people’s lives through meaningful
innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6 billion
and employs approximately 122,000 employees with sales and services in more than
100 countries. The company is a leader in cardiac care, acute care and home
healthcare, energy efficient lighting solutions and new lighting applications,
as well as male shaving and grooming, home and portable entertainment and oral
healthcare. News from Philips is located at www.philips.com/newscenter